|
| Palbociclib Impurity 87 Basic information |
Product Name: | Palbociclib Impurity 87 | Synonyms: | Palbociclib Impurity 87;6-acetyl-8-cyclopentyl-5-methyl-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one;Palbociclib impurity 32/Pyrido[2,3-d]pyrimidin-7(8H)-one,6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino];Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]-;N-Methyl Palbociclib;6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one (Palbociclib Impurity);Pabucilib impurity 42 | CAS: | 571189-51-0 | MF: | C25H31N7O2 | MW: | 461.56 | EINECS: | | Product Categories: | | Mol File: | 571189-51-0.mol | |
| Palbociclib Impurity 87 Chemical Properties |
Boiling point | 690.2±65.0 °C(Predicted) | density | 1.297±0.06 g/cm3(Predicted) | pka | 7.39±0.42(Predicted) | form | Solid | color | Light yellow to yellow |
| Palbociclib Impurity 87 Usage And Synthesis |
Uses | N-Methyl Palbociclib is an impurity of Palbociclib (P139900), a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 which may be useful in the treatment of breast cancer. |
| Palbociclib Impurity 87 Preparation Products And Raw materials |
|